Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Breast cancer anti-estrogen resistance 1 pseudogene 1 (BCAR1P1)
- Target
- BCAR1P1
- Molecular classification
- Other (Pseudogene)
01
Overview
BCAR1 pseudogene 1 (BCAR1P1) is classified as a pseudogene of the protein-coding gene BCAR1 (breast cancer anti-estrogen resistance 1), but it does not produce a protein product, is not a receptor, and has no verified biological or therapeutic relevance. Pseudogenes like BCAR1P1 are generally considered genomic elements that have lost their protein-coding ability due to mutations and lack the functions associated with their parental genes. Care should be taken not to confuse BCAR1P1 with BCAR1, as only the latter is directly implicated in cell signaling, adhesion, cancer biology, and has been considered a potential therapeutic target, albeit a challenging one due to its adaptor role and non-enzymatic nature[1][2][3][5]. If you were seeking information on the functional BCAR1 protein (not the pseudogene), please clarify, as BCAR1 is biologically relevant, while BCAR1P1 is not a validated target of pharmacologic or diagnostic interest.
- Other names
- BCAR1P1breast cancer anti-estrogen resistance 1 pseudogene 1
02
Biological functions
None known for BCAR1P1No established direct functions, since pseudogenes generally do not encode proteins. If any regulatory RNA function exists, it has not been described for BCAR1P1.
03
Disease associations
None established for BCAR1P1No reports in the literature or gene/protein databases linking BCAR1P1 specifically to disease. Disease-related information is for BCAR1, not BCAR1P1.
Beyond the preview
Go deeper on Breast cancer anti-estrogen resistance 1 pseudogene 1 (BCAR1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Breast cancer anti-estrogen resistance 1 pseudogene 1 (BCAR1P1).